AAAAAA
Results: 51-75/366
Authors:
BUTCHER NJ
ILETT KF
MINCHIN RF
Citation: Nj. Butcher et al., FUNCTIONAL POLYMORPHISM OF THE HUMAN ARYLAMINE N-ACETYLTRANSFERASE TYPE-1 GENE CAUSED BY (CT)-T-190 AND G(560)A MUTATIONS, Pharmacogenetics, 8(1), 1998, pp. 67-72
MOLECULAR-BASIS OF THE DARK AGOUTI RAT DRUG OXIDATION POLYMORPHISM - IMPORTANCE OF CYP2D1 AND CYP2D2
Authors:
YAMAMOTO Y
TASAKI T
NAKAMURA A
IWATA H
KAZUSAKA A
GONZALEZ FJ
FUJITA S
Citation: Y. Yamamoto et al., MOLECULAR-BASIS OF THE DARK AGOUTI RAT DRUG OXIDATION POLYMORPHISM - IMPORTANCE OF CYP2D1 AND CYP2D2, Pharmacogenetics, 8(1), 1998, pp. 73-82
Authors:
MASIMIREMBWA CM
DANDARA C
SOMMERS DK
SNYMAN JR
HASLER JA
Citation: Cm. Masimirembwa et al., GENETIC-POLYMORPHISM OF CYTOCHROME P4501A1, MICROSOMAL EPOXIDE HYDROLASE, AND GLUTATHIONE S-TRANSFERASES M1 AND T1 IN ZIMBABWEANS AND VENDAOF SOUTHERN AFRICA, Pharmacogenetics, 8(1), 1998, pp. 83-85
Authors:
MAMIYA K
IEIRI I
MIYAHARA S
IMAI J
FURUUMI H
FUKUMAKI Y
NINOMIYA H
TASHIRO N
YAMADA H
HIGUCHI S
Citation: K. Mamiya et al., ASSOCIATION OF POLYMORPHISMS IN THE CYTOCHROME-P450 (CYP) 2C19 AND 2C18 GENES IN JAPANESE EPILEPTIC PATIENTS, Pharmacogenetics, 8(1), 1998, pp. 87-90
Authors:
NEBERT DW
Citation: Dw. Nebert, PHARMACOGENETICS - 65 CANDLES ON THE CAKE, Pharmacogenetics, 7(6), 1997, pp. 435-440
Authors:
TRELUYER JM
GUERET G
CHERON G
SONNIER M
CRESTEIL T
Citation: Jm. Treluyer et al., DEVELOPMENTAL EXPRESSION OF CYP2C AND CYP2C-DEPENDENT ACTIVITIES IN THE HUMAN LIVER - IN-VIVO IN-VITRO CORRELATION AND INDUCIBILITY/, Pharmacogenetics, 7(6), 1997, pp. 441-452
Authors:
KOHLER D
HARTTER S
FUCHS K
SIEGHART W
HIEMKE C
Citation: D. Kohler et al., CYP2D6 GENOTYPE AND PHENOTYPING BY DETERMINATION OF DEXTROMETHORPHAN AND METABOLITES IN SERUM OF HEALTHY CONTROLS AND OF PATIENTS UNDER PSYCHOTROPIC MEDICATION, Pharmacogenetics, 7(6), 1997, pp. 453-461
Authors:
KELSEY KT
WRENSCH M
ZUO ZF
MIIKE R
WIENCKE JK
Citation: Kt. Kelsey et al., A POPULATION-BASED CASE-CONTROL STUDY OF THE CYP2D6 AND GSTT1 POLYMORPHISMS AND MALIGNANT BRAIN-TUMORS, Pharmacogenetics, 7(6), 1997, pp. 463-468
Authors:
GELBOIN HV
KRAUSZ KW
SHOU M
GONZALEZ FJ
YANG TJ
Citation: Hv. Gelboin et al., A MONOCLONAL-ANTIBODY INHIBITORY TO HUMAN P450 2D6 - A PARADIGM FOR USE IN COMBINATORIAL DETERMINATION OF INDIVIDUAL P450 ROLE IN SPECIFIC DRUG TISSUE METABOLISM, Pharmacogenetics, 7(6), 1997, pp. 469-477
Authors:
THOMPSON J
THOMAS N
SINGLETON A
PIGGOTT M
LLOYD S
PERRY EK
MORRIS CM
PERRY RH
FERRIER IN
COURT JA
Citation: J. Thompson et al., D2 DOPAMINE-RECEPTOR GENE (DRD2) TAQ1-A POLYMORPHISM - REDUCED DOPAMINE D2 RECEPTOR-BINDING IN THE HUMAN STRIATUM ASSOCIATED WITH THE A1 ALLELE, Pharmacogenetics, 7(6), 1997, pp. 479-484
Authors:
CIOTTI M
MARRONE A
POTTER C
OWENS IS
Citation: M. Ciotti et al., GENETIC-POLYMORPHISM IN THE HUMAN UGT1A6 (PLANAR PHENOL) UDP-GLUCURONOSYLTRANSFERASE - PHARMACOLOGICAL IMPLICATIONS, Pharmacogenetics, 7(6), 1997, pp. 485-495
Authors:
THITHAPANDHA A
Citation: A. Thithapandha, A PHARMACOGENETIC STUDY OF TRIMETHYLAMINURIA IN ORIENTALS, Pharmacogenetics, 7(6), 1997, pp. 497-501
Authors:
XIE HG
XU ZH
OUYANG DS
SHU Y
YANG DL
WANG JS
YAN XD
HUANG SL
WANG W
ZHOU HH
Citation: Hg. Xie et al., METAANALYSIS OF PHENOTYPE AND GENOTYPE OF NAT2 DEFICIENCY IN CHINESE POPULATIONS, Pharmacogenetics, 7(6), 1997, pp. 503-514
Authors:
JOURENKOVA N
REINIKANEN M
BOUCHARDY C
HUSGAFVELPURSIAINEN K
DAYER P
BENHAMOU S
HIRVONEN A
Citation: N. Jourenkova et al., EFFECTS OF GLUTATHIONE S-TRANSFERASES GSTM1 AND GSTT1 GENOTYPES ON LUNG-CANCER RISK IN SMOKERS, Pharmacogenetics, 7(6), 1997, pp. 515-518
Authors:
DELOMENIE C
MATHELIERFUSADE P
LONGUEMAUX S
ROZENBAUM W
LEYNADIER F
KRISHNAMOORTHY R
DUPRET JM
Citation: C. Delomenie et al., GLUTATHIONE-S-TRANSFERASE (GSTM1) NULL GENOTYPE AND SULFONAMIDE INTOLERANCE IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Pharmacogenetics, 7(6), 1997, pp. 519-520
Authors:
LERMAN C
SHIELDS PG
MAIN D
AUDRAIN J
ROTH J
BOYD NR
CAPORASO NE
Citation: C. Lerman et al., LACK OF ASSOCIATION OF TYROSINE-HYDROXYLASE GENETIC-POLYMORPHISM WITHCIGARETTE-SMOKING, Pharmacogenetics, 7(6), 1997, pp. 521-524
Authors:
DECASTRO IP
IBANEZ A
TORRES P
SAIZRUIZ J
FERNANDEZPIQUERAS J
Citation: Ip. Decastro et al., GENETIC ASSOCIATION STUDY BETWEEN PATHOLOGICAL GAMBLING AND A FUNCTIONAL DNA POLYMORPHISM AT THE D4 RECEPTOR GENE, Pharmacogenetics, 7(5), 1997, pp. 345-348
Authors:
LI T
VALLADA H
CURTIS D
ARRANZ M
XU K
CAI GQ
DENG H
LIU J
MURRAY R
LIU XH
COLLIER DA
Citation: T. Li et al., CATECHOL-O-METHYLTRANSFERASE VAL158MET POLYMORPHISM - FREQUENCY-ANALYSIS IN HAN CHINESE SUBJECTS AND ALLELIC ASSOCIATION OF THE LOW ACTIVITY ALLELE WITH BIPOLAR AFFECTIVE-DISORDER, Pharmacogenetics, 7(5), 1997, pp. 349-353
Authors:
TYRING G
NORDIN J
BERGMAN T
BERTILSSON L
Citation: G. Tyring et al., AN S-MEPHENYTOIN CYSTEINE CONJUGATE IDENTIFIED IN URINE OF EXTENSIVE BUT NOT OF POOR METABOLIZERS OF S-MEPHENYTOIN, Pharmacogenetics, 7(5), 1997, pp. 355-360
Authors:
STEWARD DJ
HAINING RL
HENNE KR
DAVIS G
RUSHMORE TH
TRAGER WF
RETTIE AE
Citation: Dj. Steward et al., GENETIC ASSOCIATION BETWEEN SENSITIVITY TO WARFARIN AND EXPRESSION OFCYP2C9-ASTERISK-3, Pharmacogenetics, 7(5), 1997, pp. 361-367
Authors:
YASUI N
TYBRING G
OTANI K
MIHARA K
SUZUKI A
SVENSSON JO
KANEKO S
Citation: N. Yasui et al., EFFECTS OF THIORIDAZINE, AN INHIBITOR OF CYP2D6, ON THE STEADY-STATE PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND ITS ACTIVE METABOLITE, DESMETHYLMIANSERIN, IN DEPRESSED JAPANESE PATIENTS, Pharmacogenetics, 7(5), 1997, pp. 369-374
Authors:
TYNDALE RF
DROLL KP
SELLERS EM
Citation: Rf. Tyndale et al., GENETICALLY DEFICIENT CYP2D6 METABOLISM PROVIDES PROTECTION AGAINST ORAL OPIATE DEPENDENCE, Pharmacogenetics, 7(5), 1997, pp. 375-379
Authors:
LESSARD E
FORTIN A
BELANGER PM
BEAUNE P
HAMELIN BA
TURGEON J
Citation: E. Lessard et al., ROLE OF CYP2D6 IN THE N-HYDROXYLATION OF PROCAINAMIDE, Pharmacogenetics, 7(5), 1997, pp. 381-390
Authors:
FUKUDA K
OHTA T
OSHIMA Y
OHASHI N
YOSHIKAWA M
YAMAZOE Y
Citation: K. Fukuda et al., SPECIFIC CYP3A4 INHIBITORS IN GRAPEFRUIT JUICE - FUROCOUMARIN DIMERS AS COMPONENTS OF DRUG-INTERACTION, Pharmacogenetics, 7(5), 1997, pp. 391-396
Authors:
BAYOUMI RAL
QURESHI MM
ALAMERI MM
WOOLHOUSE NM
Citation: Ral. Bayoumi et al., THE N-ACETYLTRANSFERASE G(191)A MUTATION AMONG SUDANESE AND SOMALIS, Pharmacogenetics, 7(5), 1997, pp. 397-399